Back

Impact of baseline hemoglobin level and white blood cell count in real-world patients undergoing contemporary percutaneous coronary intervention: insights from the GLOBAL LEADER study

2 September 2019 (11:00 - 11:15)
Organised by:
Congress Presentation Part of: Optimal treatment of coronary artery disease Comorbidities ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ply Chichareon

Prince of Songkla University, Hat Yai (Thailand)

4 More presentations in this session

Presentation thumbnail
Exercise training ameliorates vasodilator capacity of coronary microvessels in patients with vasospastic angina -A new therapeutic approach for the coronary functional disorder-
Doctor J. Sugisawa (Sendai, JP)
Abstract
Presentation thumbnail
Contemporary mortality rates in myocardial infarction patients in Sweden: a tale of two registries
Mr J. Siverskog (Linkoping, SE)
Abstract Slides Video
Presentation thumbnail
Updated meta-analysis of biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent implantations
Doctor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
First-line coronary computed tomography predicts long-term clinical outcome in patients with Non-ST-segment elevation acute coronary syndrome - The VERDICT trial
Associate Professor K. Kofoed (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Optimal treatment of coronary artery disease

The Event

Event poster

ESC Congress 2019

2 September 2019 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources